The Next Web1d
Will AI revolutionise drug development? Researchers say it depends on how it’s used
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
JD Supra6d
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
News Medical on MSN13d
New AI software could speed up drug development
The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...
Hosted on MSN23d
Drug candidates target metabolic pathway in bacteria while sparing human cells
This principle is an important basis for the development of antibiotics ... If the MEP pathway in bacteria is blocked, for example by a drug, the bacteria can no longer produce a number of ...
The Highland County Press11h
FDA approves novel non-opioid treatment for moderate to severe acute pain
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...
FDA approves painkiller designed to eliminate risk of addiction associated with opioids
Washington — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...